Literature DB >> 791534

George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis.

E Haber.   

Abstract

Recently, the availability of a number of specific inhibitors of the renin-angiotensin system has made it possible to address certain critical questions concerning the role of angiotensin II in physiologic homeostasis and in a number of pathologic states. These studies indicate that angiotensin II does not have an obligatory role in blood pressure maintenance in the normal, sodium replete individual, but it is essential following sodium depletion. The role of angiotensin II in feedback control of renin secretion is confirmed as is its importance in aldosterone stimulation both in relation to posture and sodium depletion. Angiotensin II is responsible for the initial pressor response of experimental renovascular hypertension and appears to be important in the initiation of chronic renovascular hypertension. Converting enzyme blockers and competitive inhibitors of angiotensin II are helpful in the diagnosis of clinical renovascular hypertension and in the identification of renin dependent hypertensives. Homeostatic mechanisms leading to maintenance of blood pressure and accumulation of edema in experimental congestive heart failure appear to be dependent on angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791534     DOI: 10.1161/01.cir.54.6.849

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Humoral and neurohormonal aspects of blood pressure regulation: focus on angiotensin.

Authors:  D Ganten; G Stock
Journal:  Klin Wochenschr       Date:  1978

2.  The vasopressor system in patients with heart failure due to idiopathic dilated cardiomyopathy--influence of the clinical stage of disease and of chronic drug treatment.

Authors:  V Mitrovic; J Thormann; P Kornecki; M Volz; H Neuss; M Schlepper
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

Review 3.  Interactions of the renin-angiotensin system in colorectal cancer and metastasis.

Authors:  W Kurtis Childers
Journal:  Int J Colorectal Dis       Date:  2015-01-17       Impact factor: 2.571

4.  Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.

Authors:  T Hata; T Ogihara; H Mikami; M Nakamaru; T Mandai; Y Kumahara
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

Review 5.  Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist.

Authors:  Anil Verma; Scott D Solomon
Journal:  Curr Heart Fail Rep       Date:  2007-12

6.  New renin inhibitors homologous with pepstatin.

Authors:  M Eid; G Evin; B Castro; J Menard; P Corvol
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

7.  Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.

Authors:  D N Sharpe; R J Coxon
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.

Authors:  T Hata; T Ogihara; M Nakamaru; S Gotoh; K Masuo; S Saeki; A Kumagai; Y Kumahara
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.

Authors:  G A MacGregor; N D Markandu; J Bayliss; J E Roulston; M Squires; J J Morton
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-08

10.  Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.

Authors:  Hanna Andersson; Mathias Hallberg
Journal:  Int J Hypertens       Date:  2012-12-04       Impact factor: 2.420

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.